In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas

Br J Haematol. 2019 Jul;186(1):149-152. doi: 10.1111/bjh.15727. Epub 2018 Dec 19.
No abstract available

Keywords: T-cell lymphoma; chemotherapy; ibrutinib; idelalisib; lymphomas.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Synergism*
  • Humans
  • Isoquinolines / therapeutic use*
  • Lymphoma / drug therapy*
  • Piperidines
  • Purines / therapeutic use
  • Pyrazoles / therapeutic use
  • Pyrimidines / therapeutic use
  • Quinazolinones / therapeutic use

Substances

  • Antineoplastic Agents
  • Isoquinolines
  • Piperidines
  • Purines
  • Pyrazoles
  • Pyrimidines
  • Quinazolinones
  • ibrutinib
  • pixantrone
  • Adenine
  • idelalisib